BDBM237707 US10052306, 253::rac-(3aR,5r,6aS)-5-(3,4- difluorobenzyl)-2-(2- hydroxy-2-(4- hydroxyphenyl)ethyl) octahydrocyclopenta[c] pyrrol-5-ol

SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccc(F)c(F)c3)C[C@H]2C1)c1ccc(O)cc1

InChI Key InChIKey=YYVNNDBAOACWMO-WDODAKIKSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 237707   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM237707(US10052306, 253 | rac-(3aR,5r,6aS)-5-(3,4- difluor...)
Affinity DataIC50:  31.5nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent